389573-45-9,
((3R,4S)-rel-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl)methanol,
((3R,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol,
109887-53-8,
UNII-XC4L1C104G,
XC4L1C104G,
(+/-)-TRANS-4-(FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE,
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4S)-,
3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4S)-rel-,
(+)-Paroxol,
C13H18FNO,
[(3R,4S)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl]methanol,
318279-38-8,
Paroxol, (+)-,
Paroxol, trans-(+)-,
(+)-trans-4-(4'-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine,
SCHEMBL3921318,
Jsp000773,
CTK1B4488,
DTXSID10430930,
KS-00001G0Z,
ZINC2576820,
5056AB,
ANW-72346,
AKOS015851031,
AB14230,
AJ-42561,
AK-56965,
BC681109,
AX8014894,
AX8209312,
TC-071796,
FT-0673524,
K-7477,
[(3R,4S)-4-(4-Fluorophenyl)-1-methylpiperidinyl]methanol,
1-Methyl-4beta-(4-fluorophenyl)piperidine-3alpha-methanol,
UNII-QRA30YT0AV component CXRHUYYZISIIMT-DGCLKSJQSA-N,
(-)trans-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine,
ent-Paroxol,
UNII-QRA30YT0AV,
CXRHUYYZISIIMT-DGCLKSJQSA-N,
CID9800834,
EC 415-550-0,
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine,
[4-(4-fluorophenyl)-1-methyl-3-piperidyl]methanol,
105812-81-5,
(+/-)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine,
4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-methylpiperidine, (+/-)-trans-,